BiomX Inc (PHGE)
0.479
+0.10
(+26.12%)
USD |
NYAM |
Apr 30, 16:00
0.4548
-0.02
(-5.05%)
After-Hours: 06:57
BiomX Cash from Operations (TTM): -21.29M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.29M |
| September 30, 2023 | -22.21M |
| June 30, 2023 | -21.77M |
| March 31, 2023 | -26.77M |
| December 31, 2022 | -29.09M |
| September 30, 2022 | -31.01M |
| June 30, 2022 | -31.22M |
| March 31, 2022 | -28.58M |
| December 31, 2021 | -27.57M |
| Date | Value |
|---|---|
| September 30, 2021 | -25.60M |
| June 30, 2021 | -25.84M |
| March 31, 2021 | -23.95M |
| December 31, 2020 | -24.45M |
| September 30, 2020 | -17.59M |
| June 30, 2020 | -11.78M |
| March 31, 2020 | -7.248M |
| September 30, 2019 | -0.4738M |
| June 30, 2019 | -0.2046M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-31.22M
Minimum
Jun 2022
-0.2046M
Maximum
Jun 2019
-20.93M
Average
-24.20M
Median
Cash from Operations (TTM) Benchmarks
| Taro Pharmaceutical Industries Ltd | 142.87M |
| InspireMD Inc | -16.38M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -18.47M |
| Raphael Pharmaceutical Inc | -1.203M |